Proteom Capital - using genetic engineering techniques in investment analysis 
 
   
Applying quantitiative econometrics and bioengineering to investment finance 
 
 search Proteom
 

G000 Strategic Volatility Fund

Investment Objectives:

Returns of around 10%-15% with single digit volatility, uncorrelated with equity indices.

Portfolio Composition: Long and short option positions in S&P500 index member stocks and US equity indices.
Methodology: Click here for details.
Testing: Click here for details.
2-Page Summary: Click here.
PowerPoint Presentations:
Strategy Technical
Detailed Zephyr Report: Click here.
Detailed Strategy Analysis: Click here.
Data file of returns: Click here (MS-Excel format)
Sample portfolios Click here (Zip file MS-Excel format)

Performance Summary

 

Oct 2002 - Dec 2004

SP500

G000

Compound Return 19.06% 12.90%
Downside Risk 10.44% 4.33%
Volatility 16.25% 6.92%
Beta   -0.02
Sharpe 1.13 1.76
Information Ratio   -0.34

Annualized Alpha

 

12.88%

Monthly Returns*

Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Year
2004 -1.81 1.60 1.78 -0.38 0.89 0.68 1.16 2.11 0.00 2.51 2.84 1.39 13.21
2003 2.51 10.45 0.49 -0.71 -1.46 -0.62 0.34 2.18 -0.19 1.35 1.99 -1.83 14.88
2002                   -1.15 -.10 2.36 1.09
*Calculated on daily return data using Zephyr Style Advisor. 
 
Copyright © 2003-2007 Proteom Capital Management Ltd. All rights reserved.